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Biocatalytic induced Surface Modification of the Tobacco Mosaic 
Virus and the Bacteriophage M13  
Valentina Vignali,a+ Barbara S. Miranda,a,b+ Irene Lodoso-Torrecilla,a Cathelijn A. J. van Nisselroy,a 
Bas-Jan Hoogenberg,a Sybren Dantuma,a Frank Hollmann,c Jan Willem de Vries,d Eliza M. 
Warszawik,d Rainer Fischer,e Ulrich Commandeur,e Patrick van Rijna,d* 
Engineered viruses are finding an increasing number of 
applications in basic, translational research and material science. 
The genetic and chemical engineering of the capsids represents a 
key point for tailoring the properties of viral particles, but the 
synthetic efforts and limits accompanying these processes still 
hinder their usability. Here, a single-step highly selective 
biocatalytic functionalization approach is shown, providing a 
general platform for virus-acrylate hybrid particles. The tobacco 
mosaic virus (TMV) and the bacteriophage M13 have been 
successfully modified via laccase induced free radical formation on 
the tyrosine residues through a single electron oxidation as 
initiating step that subsequently reacts with acrylate-based 
monomers. This new approach can be extended to other 
biomolecular assemblies with surface exposed tyrosine residues, 
when the introduction of new functionalities is desired. 
Engineered bionanostructures have great potential in 
drug/gene delivery systems, nanoelectronics, liquid crystals, 
and biosensors. Virus particles (VPs) are promising 
bionanomaterials in the aforementioned applications and have 
so far been used as nanocarrier platforms, nanoreactors, 
probes for imaging and sensing platforms.1 The applications of 
VPs can be modulated through the addition of new 
functionalities to their surface via genetic or synthetic 
modifications, which can also be sequentially performed.2 
Although, these techniques offer great possibilities, they still 
present some limitations. Genetic modifications, are restricted 
to the introduction of natural or unnatural peptides that 
ensure the capsid formation preferably with a high production 
yield, these two requirements combined is a challenging 
process.3 Chemical engineering offers the possibility to 
decorate viruses with a broad spectrum of functional groups 
such as fluorophores, inorganic structures, hydrophobic or 
charged moieties and stealth polymers.4 Several synthetic 
routes have been explored and despite surface modification 
can be achieved, a proper balance in terms of high specificity 
and viral structure maintenance is needed.5 Promising 
strategies as alternatives to the use of the conventional 
peptide-coupling based chemistry consist of the 
functionalization of the tyrosine residues through diazonium 
coupling,6 which allows for subsequent modification such as by 
copper-catalyzed azide-alkyne cycloaddition (CuAAC).7 
However, new approaches with less synthetic efforts, high 
chemical diversity, limited number of synthetic steps, and 
associated purifications are desired in order to facilitate future 
applications of viral particles.  
Tyrosine residues can be enzymatically activated by laccase via 
a single electron oxidation step producing a free radical 
species.8 It was envisioned that the free radical could be used 
as a new grafting-from approach to modify the viral surface 
using laccase combined with a large  library of acrylates, which 
offers a tremendous chemical variability. Laccases are 
commercially available and require mild reaction conditions. 
Furthermore, as coenzyme-independent oxidoreductases they 
are very simple to use, requiring molecular oxygen as 
cosubstrate and producing water as sole by-product.9 The 
laccase-induced tyrosine oxidation generates a radical 
intermediate on the viral surface, which subsequently can 
react with acrylate-based monomer units. Depending on the 
monomer, various novel properties can be introduced 
(Scheme 1).  
The tobacco mosaic virus (TMV) and the bacteriophage M13 
(M13) have been modified via the aforementioned biocatalytic 
approach. These two viruses have already proven their 
applicability in nanomedicine and material science,10 but 
improvements on attaining a higher chemical diversity without 
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the requirement of a complicated synthesis are needed in 
order to promote their large-scale application. 
TMV is made up of 2130 coat protein (CP) subunits self-
assembled in a helical fashion around a single strand RNA, 
forming tubes of 18 nm in diameter and 300 nm in length11 
and its coat protein presents one accessible tyrosine in 
position 139.6 The filamentous bacteriophage M13 is made up 
of 2700 copies of a major coat protein, p8, and few copies of 
minor coat proteins that enclose a circular single-stranded 
DNA molecule. The protein p8 presents two accessible 
tyrosines in position 21 and 24.12 To demonstrate the ease of 
introducing chemical variability, molecular modifications using 
monomers that are hydrophilic, hydrophobic, charged, 
responsive, and fluorescent were performed. The reaction is 
straightforward and able to be combined with different types 
of commercially available acrylates and other monomers, 
therefore this grafting from approach is extremely versatile 
with the possibility to introduce diverse chemical species. 
Before applying this reaction to the viruses, the enzyme 
performance has been tested, on the basis of a previous 
work,13 at different pH, temperatures, and time of oxygen 
removal. Phenol was used as a model oxidation-initiator to 
mimic the tyrosine residue of the viral surface (Supporting 
Information, S1). The optimum conditions for yielding the 
highest amount of grafted monomers were determined to be 
phosphate buffer 0.1 molL-1 at pH 6-7.5 and 65-75°C. For TMV 
modification, these conditions have been slightly adjusted to 
meet the integrity maintenance requirements compatibly. 
Although TMV is a robust bionanoparticle, it can still denature 
if maintained at high temperature for prolonged time14 and 
disassemble into smaller disk-like aggregates above pH 6.5.15 
To minimize denaturation and changes in aggregate 
morphology, a reaction mixture of 0.1 molL-1 phosphate buffer 
pH 6 at 60 °C for 90 minutes was used. For M13, the reaction 
temperature has been lowered to 35 °C.  
Different acrylate monomers were used: [2-
(Methacryloyloxy)ethyl]trimethylammonium chloride 
(METAC), N-Isopropylacrylamide (NIPAAm), N-
Vinylcaprolactam (VCL), Styrene (Styr) and Fluorescein o-
acrylate. These monomers were chosen due to their potential 
to add interesting properties to the viruses and also to 
evaluate the versatility of this new method to add diverse 
chemical functionalities. Additionally, Fluorescein o-acrylate 
was used as co-monomer at 1% or 10% together with the 
respective monomers for providing a further control during 
the characterization steps and to produce fluorescent virus-
hybrid particles. It is worth mentioning that styrene was 
dissolved in ethanol before being added to the reaction 
mixture, which had a final ethanol content of 10% (v/v). The 
addition of ethanol ensures sufficient solubility of styrene 
without denaturing TMV while maintaining appropriate 
laccase activity, which is known to tolerate organic solvents up 
to 30% (v/v).13 After the reaction, the mixture was purified by 
dialysis against MilliQ water and characterized by transmission 
electron microscopy (TEM) (Figure 1, Supporting Information 
SI2), matrix-assisted laser desorption/ionization time of flight 
mass spectrometry (MALDI-ToF) (Figure 2A, Supporting 
Information SI3), reversed-phase liquid chromatography 
(RPLC) (Figure 2B), sodium dodecyl sulfate polyacrylamide gel 
electrophoresis  (SDS-PAGE) (Supporting Information, SI4), and 
fluorescence spectrometry (Supporting Information, SI5).  
TEM images of the TMV and M13 modified particles reveal 
that the viral structure is maintained, indicating the stability 
towards the reaction conditions (Figure 1). The unmodified 
TMV and M13 normally appear as single linear filaments while 
the hybrid particles occur in an assembled state, which is 
probably caused by a drying effect related to the altered 
surface properties. In general, longer structures were observed 
for the TMV. Hybrid particles are assembled in a head-to-tail 
manner even when the TMV concentration was reduced in the 
reaction mixture. This occurs most likely due to interaction 
between the hydrophobic ends, which was also found in 
previous studies with polyaniline deposition onto the surface 
of TMV.16 
Scheme 1. Modification of the tobacco mosaic virus via laccase induced free-radical 
oxidation. Laccase oxidizes the exposed tyrosine residues on the viral surface and the 
phenolic radicals newly formed triggers the functionalization of acrylate monomers. 
TMV structure created from the RCSB PDB (www.rcsb.org) of PDB ID 2OM3.13  
Figure 1. Transmission Electron Micrographs of the virus particles. A) M13 unmodified 
B) M13-NIPAM hybrid C) TMV unmodified D) TMV-NIPAM hybrid.
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The covalent nature of the monomer grafting to the viral 
surface has been verified through MALDI-ToF and reversed-
phase liquid chromatography as well as by SDS-PAGE. The 
MALDI-ToF spectrum of the unmodified TMV (Figure 2A) is 
presented as a single narrow signal correspondent to a mass of 
17.5 kDa, which can be attributed to the TMV CP. In the 
spectra of the viral particles from the biocatalytic modification 
(Figure 2A, Supporting Information, Figure S3), the peak at 
17.5 kDa is still present, but additionally another broad signal 
representing heavier species is detected. This indicates that 
the products of the reactions are particles made up of a 
mixture of modified and unmodified CPs. The presence of the 
latter is probably due to the fact that the laccase needs time 
and spatial freedom to properly activate the tyrosines and 
during the activation and modification, other tyrosine moieties 
located nearby are most likely sterically hindered. The 
distribution representing the modified CPs indicates that the 
obtained conjugates are not monodisperse, which is to be 
expected from a free radical approach. Analyzing the signals, it 
has been determined that with this biocatalytic approach it 
was possible to graft oligomeric structure composed of more 
than 15 monomer units of NIPAAm on a single protein, and 
over 10 units of VCL and METAC. Through the integration of 
the signals provided by MALDI-ToF, the degree of modification 
for each type of acrylate was assessed (Supporting 
Information, Table S1). The unmodified CPs and the CP 
conjugates of the TMV capsids were separated via reversed-
phase chromatography (Figure 2B). However, the modification 
of the tyrosine moiety from a phenol-like structure to an 
alkylated phenol affected the UV-Vis absorption such that the 
detection of the CP was hindered, causing the isolation of the 
eluted CP conjugates to be challenging. However, by 
introducing a fluorescent co-monomer it was nevertheless 
possible to unambiguously differentiate between CP 
conjugates and unmodified CPs using an alternative 
wavelength of detection at which only the eluted conjugate 
produces a signal (Figure 2B inset). The MALDI-ToF analysis of 
the isolated fraction shows a peak at 17.677 kDa with a mass 
corresponding to the functionalized CP, whilst the 
characteristic peak of the unmodified TMV CP is absent (Figure 
2A). This indicates that the modification is of covalent, rather 
than of non-covalent, nature. As can be seen from the SDS-
PAGE of the viral particles (Supporting Information, Figure S4), 
the unmodified TMV contains a majority of sub-units with a 
molecular weight (Mw) of approximately 17 kDa. A small band 
around 35kDa is also present, probably corresponding to CP 
dimers whose interactions are resistant to the denaturing 
conditions of the SDS-page. On the other hand, all TMV-
modified hybrids presented a protein band more distributed 
towards higher molecular weight than 17 kDa. Additionally, 
there is a large build-up around two times the molecular 
weight of the CP. This can suggest that the presence of new 
functionalities can stabilize the interaction between dimers, as 
previously observed for the unmodified TMV. The overall 
result provides the supporting evidence that CP conjugates of 
a higher molecular weight than the unmodified CP are formed, 
as it was observed by MALDI-ToF, further emphasizing the 
covalent nature of the modification through the free radical 
biocatalytic grafting reaction.  
To investigate the potential of introducing new properties 
onto the viral surface through this functionalization, the 
fluorescence signal of the fluorescein o-acrylate virus-hybrids 
has also been measured (Supporting Information, Figure S5). 
Both the TMV and M13 hybrids were emitting a well 
detectable signal not only when functionalized solely with 
fluorescein o-acrylate but also when the fluorophore was 
added as 10% co-monomer in the reaction with another 
monomer, NIPAAm. 
 
In summary, a new biocatalytic route has been demonstrated 
to modify TMV and M13 with chemically diverse oligomeric 
structures with a wide variety of properties in an easy and 
straightforward approach to tailor the overall properties of 
such particles. This new synthetic approach enables virus 
particles to become more generally applicable due to less 
synthetic efforts. Although TMV and M13 were used in this 
study, the approach is not limited to these viruses and any 
tyrosine-bearing protein structure can be potentially modified 
in this fashion. When protein-based particles are used for 
therapeutic applications, they trigger an immune response, 
which leads to particle degradation. This disadvantage offers 
an additional motivation for pursuing easy protein 
modification with polymer forming approaches, in fact the 
grafting of “stealth” monomers to proteins through this 
biocatalytic approach, could allow prolonged non-detection 
times by the immune system improving the pharmacokinetic 
profile.17 Moreover, the exposure of tyrosine in vivo may lead 
to the nitration of this residue which is known to trigger an 
immune response.18  Therefore, in addition to provide a 
general synthetic tool for advancing the use of 
bionanostructures in various applications, targeting and 
modifying the tyrosine residue as presented here is regarded 
as a dual approach to potentially lower the immune 
recognition. 
Figure 2. MALDI-ToF spectra and RPLC elugrams of TMV particles. A) From the top to 
the bottom MALDI-ToF spectra of CP derived from TMV unmodified particles, CP 
derived from TMV-VCL hybrids, CP functionalized fraction isolated through RPLC from 
TMV-VCL fluorescent hybrids. B) RPLC elugrams (detection at 254nm) of CP derived 
from TMV unmodified particles, CP derived from TMV-VCL hybrids, CP derived from 
TMV-VCL fluorescent hybrids. Inset elugram (detection at 443) of TMV-VCL fluorescent 
hybrids.
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Experimental section 
The modification of the virus particles took place in a one-step 
one-pot reaction where 1 mgmL-1 of TMV and 68 gmL-1 of 
bacteriophage M13 were mixed together with 7 mM of the 
respective monomers (for chromophore-labeled viruses, 
fluorescein-acrylate was added as co-monomer at 1 mol% or 
10 mol%) and 0.05 mmolL-1 of laccase in 0.1 molL-1 phosphate 
buffer pH 6.0. The activation of the enzyme started by heating 
the reaction mixture in a water bath at 60°C for 5 minutes for 
TMV and at 35°C for 5 minutes for the bacteriophage M13, 
then the reaction solution was purged for 1 minute with 
nitrogen to eliminate dissolved O2 and prevent a premature 
termination of the reaction. After that, the mixtures were left 
immerged in the water bath for 1 hour and a half in total. At 
the end, as a strategy to stop the reaction and to remove 
unreacted monomers, the reaction were placed for dialysis 
against MilliQ water in an 6000-8000 Da membrane for 48 
hours at room temperature. All measurements and analysis 
were after the dialysis step.  
Reversed-phase (RP) liquid chromatography analysis was 
performed on a Shimadzu VP series high performance liquid 
chromatography (HPLC) modular system equipped with DGU- 
14A3 Online Vacuum-Degasser, two LC-20 AT pumps, SIL-20A 
auto sampler, CTP-20 A column oven, PDA detector, FRC-10 
fraction collector and Shimadzu LCsolution software. 
Chromatographic separations were performed using Jupiter 
300 C4 column (Phenomenex) at 40OC and the samples were 
eluted at the flowrate 1mL*min-1 with a linear gradient from 0 
to 100% buffer A in buffer B (buffer A: 0.1% of TFA, 5% of ACN, 
94,9% water; buffer B: 0.1% TFA, 5% of water and 94,9% ACN) 
over the course of 40 min. Purifications was monitored with 
254nm and 443 nm. After the purification fractions containing 
the products were collected, solvents were removed under 
reduced pressure and lyophilized. 
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Through a one-step laccase induced free radical oxidation of 
tyrosine residues, the capsids of the tobacco mosaic virus (TMV) 
and the bacteriophage M13 were functionalized with different 
types of acrylates. This method provides engineered virus with 
customizable properties for the desired applications. 
